BioSpace News Archive

GlycoMimetics, Inc. announced that senior management will present corporate updates at two upcoming investor conferences in April.

RogCon Biosciences announced its participation at the World Orphan Drug Congress 2019 being held in Maryland April 10-April 12th, 2019.

Immunomic Therapeutics, Inc. announced that it will participate at the World Vaccine Congress Washington being held in Washington, D.C. April 14-17, 2019.

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced that it will report first quarter 2019 results on Tuesday, April 23, 2019, before the market opens.

Clear Spring Health is pleased to announce an agreement in principle to acquire and re-capitalize Community Care Alliance of Illinois, NFP out of rehabilitation.

Waters Corporation will webcast its Q1 2019 financial results conference call live on Tuesday, April 23rd at 8:00 a.m. eastern time.

Baxter International Inc., a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.m. Central Daylight Time.

Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces the expansion of its pipeline with a series of new mechanism antibiotics, DDS-04, which targets Enterobacteriaceae.

AiLife Diagnostics Inc., a clinical molecular diagnostic and bioinformatics company, and BGI Americas, a leading global genomic services company, announced today that they have entered into an agreement to jointly develop and market a clinical whole genome sequencing (WGS) solution for diagnosis of genetic disorders

Natural Alternatives International, Inc. is proud to announce that it has further extended its partnership with The Juice Plus+ Company, a globally recognized leader in whole-food based nutritional products focused on people’s health and well-being, through the execution of an amendment to and a three year extension of its multi-year Exclusive Manufacturing Agreement covering Juice Plus+ capsule and powder products sold in over 24 markets around the world.